Prescribing Safety at the NHS–Private Interface

The NHS–private interface is an important area of prescribing risk and requires clear clinical governance. Remote care can improve access, but safe prescribing depends on confirming identity, completing an adequate clinical assessment, reviewing medication history, allergies, and relevant risk factors, considering safeguarding issues, and arranging reliable follow-up. The clinician who signs a prescription remains professionally accountable for its safety, including monitoring needs, escalation arrangements and clear safety-netting advice.

Common communication risks include requests for NHS GPs to continue medicines without sufficient clinical information, or patients being left unclear about whether prescribing and monitoring responsibilities rest with the private provider or the NHS. Examples include an NHS GP receiving a request to continue ADHD, weight-loss or hormone treatment without baseline observations, blood results or a monitoring plan; patients being advised to seek NHS continuation before shared-care has been agreed; abnormal results not being copied to the registered GP; or urgent red-flag symptoms being recorded privately but not escalated through appropriate NHS or emergency pathways. Good practice is to obtain patient consent to inform the NHS GP, share the diagnosis, rationale, dose, duration, monitoring plan, red flags and follow-up responsibilities, and explain clearly when a medicine remains privately prescribed. If a patient declines information sharing, the prescriber should assess and document whether treatment can still be provided safely.

GMC guidance on remote consultations makes clear that the same professional standards apply remotely as in person, including consent, continuity of care and having enough information before prescribing. GPhC guidance for pharmacies providing services at a distance highlights the need for additional safeguards in online supply, including identity verification, appropriate two-way communication, independent verification, rather than relying on questionnaires alone for higher-risk medicines, and clear arrangements when patients have no GP or decline GP information sharing. CQC advice for online primary care expects robust systems for patient verification, access to relevant records, evidence-based prescribing, risk management, audit, safeguarding and escalation. Providers should therefore support collaborative care through clear prescribing policies, proportionate audit of higher-risk medicines, careful documentation of decisions that depart from guidance, and patient-facing explanations that reduce confusion about private and NHS responsibilities.

Key recommendations

• Confirm patient identity, relevant medical history, allergies, current medicines and safeguarding risks before prescribing.
• Do not rely on questionnaires alone for higher-risk medicines; use appropriate two-way clinical communication and verification.
• Obtain consent to inform the patient’s NHS GP, and document any refusal and its impact on prescribing safety.
• Share clear information with NHS GPs, including diagnosis, rationale, dose, duration, monitoring requirements, red flags and responsibilities for follow-up.
• Avoid implying that NHS GPs must continue private prescribing unless shared-care or transfer arrangements have been explicitly agreed.
• Ensure abnormal results, urgent concerns and red-flag symptoms are escalated promptly through appropriate NHS or emergency pathways.
• Maintain prescribing policies, audit high-risk medicines and document decisions that depart from usual guidance.

Conclusion

At its best, telemedicine can widen access without compromising safety; at its worst, poor coordination can leave patients exposed to avoidable prescribing harm. The priority is therefore simple: every prescription should be supported by clear clinical reasoning, timely information sharing and an explicit agreement about who is responsible for monitoring and follow-up. Providers that build these safeguards into everyday practice will protect patients, support NHS colleagues and demonstrate the governance expected of modern digital healthcare.

For support reviewing telemedicine prescribing governance, NHS–private communication pathways, shared-care processes or regulatory readiness, contact GIVE Consulting to discuss practical, proportionate improvements that strengthen patient safety and service assurance.